Annotation Detail for KCNH2


Gene Symbol: | KCNH2 ( ERG1,HERG,HERG1,Kv11.1,LQT2,SQT1 ) |
---|---|
Gene Full Name: | potassium voltage-gated channel, subfamily H (eag-related), member 2 |
Band: | 7q36.1 |
Quick Links | Entrez ID:3757; OMIM: 152427; Uniprot ID:KCNH2_HUMAN; ENSEMBL ID: ENSG00000055118; HGNC ID: 6251 |
Relate to Another Database: | SFARIGene; denovo-db |
No data |
Desease ID | Desease Name |
---|---|
1866 | Sudden infant death syndrome |
1870 | Drug abuse |
1934 | Cancer |
2075 | Heart failure |
2092 | Long QT syndrome |
Desease Name |
---|
CARDIOVASCULAR |
CHEMDEPENDENCY |
cardiac repolarization |
Electrocardiographic traits |
QT interval |
atriventricular block long QT syndrome |
cardiovascular |
EKG, abnormal |
unknown |
Desease Name |
---|
Electrocardiographic traits |
QT interval |
Desease Name |
---|
Long QT syndrome-2 |
Short QT syndrome-1 |
Long QT syndrome, acquired, susceptibility to |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C050232 | 1,3-ditolylguanidine | 1,3-ditolylguanidine results in decreased activity of KCNH2 protein | decreases activity | 17460149 |
C009505 | 4,4'-diaminodiphenylmethane | 4,4'-diaminodiphenylmethane results in decreased expression of KCNH2 mRNA | decreases expression | 18648102 |
D000143 | Acids | Acids inhibits the reaction [azimilide results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 15821840 |
D000143 | Acids | Acids inhibits the reaction [dofetilide results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 15821840 |
D000143 | Acids | Acids inhibits the reaction [Quinidine results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 15821840 |
D015761 | 4-Aminopyridine | 4-Aminopyridine results in decreased activity of KCNH2 protein | decreases activity | 19915712 |
D000638 | Amiodarone | Amiodarone binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 15272206 |
D000638 | Amiodarone | Amiodarone promotes the reaction [naringenin results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
D000638 | Amiodarone | Amiodarone results in decreased activity of KCNH2 protein | decreases activity | 16971508 11238279 10208308 18057881 15618689 15671647 18724381 15821840 16960444 |
D000638 | Amiodarone | naringenin promotes the reaction [Amiodarone results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
D000638 | Amiodarone | Potassium inhibits the reaction [Amiodarone results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 15618689 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of KCNH2 mRNA | affects expression | 16483693 |
D000677 | Amsacrine | Amsacrine binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 15148258 |
D001151 | Arsenic | Arsenic affects the expression of KCNH2 mRNA | affects expression | 18414638 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased localization of KCNH2 protein | decreases localization | 15213294 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of KCNH2 mRNA | increases expression | 15070760 |
D016589 | Astemizole | Astemizole binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 12388285 |
D016589 | Astemizole | Astemizole binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 14678746 |
D016589 | Astemizole | Astemizole affects the localization of KCNH2 protein mutant form | affects localization | 11741928 10531299 |
D016589 | Astemizole | Astemizole binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 10376921 12388285 11705456 15272206 9658196 |
D016589 | Astemizole | Astemizole binds to KCNH2 gene polymorphism | affects binding | 18701618 |
D016589 | Astemizole | Astemizole binds to KCNH2 protein | affects binding | 15272206 18701618 |
D016589 | Astemizole | Astemizole inhibits the reaction [Digoxin results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 19139152 |
D016589 | Astemizole | Astemizole inhibits the reaction [Digoxin results in decreased metabolism of KCNH2 protein modified form] | decreases metabolic processing|decreases reaction | 19139152 |
D016589 | Astemizole | Astemizole results in decreased activity of KCNH2 protein | decreases activity | 10828461 15671647 15740727 8641472 10422790 11741928 11082114 |
D016589 | Astemizole | Hydrogen Peroxide inhibits the reaction [Astemizole results in decreased activity of KCNH2 protein mutant form] | decreases activity|decreases reaction | 10828461 |
D016589 | Astemizole | Astemizole results in decreased activity of KCNH2 protein | decreases activity | 16723379 |
D016589 | Astemizole | Astemizole results in decreased activity of KCNH2 protein | decreases activity | 11040061 |
C086123 | azimilide | Acids inhibits the reaction [azimilide results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 15821840 |
C086123 | azimilide | azimilide promotes the reaction [naringenin results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
C086123 | azimilide | azimilide results in decreased activity of KCNH2 protein | decreases activity | 15821840 18057881 16960444 |
C086123 | azimilide | naringenin promotes the reaction [azimilide results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
C086123 | azimilide | Potassium inhibits the reaction [azimilide results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 16960444 |
D015764 | Bepridil | Bepridil results in decreased activity of KCNH2 protein | decreases activity | 14975710 |
D015764 | Bepridil | Bepridil binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 15272206 |
D015764 | Bepridil | Bepridil results in decreased activity of KCNH2 protein | decreases activity | 15671647 |
D047392 | beta-Cyclodextrins | beta-Cyclodextrins analog inhibits the reaction [Cisapride results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 17513944 |
D047392 | beta-Cyclodextrins | beta-Cyclodextrins analog inhibits the reaction [E 4031 results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 17513944 |
D047392 | beta-Cyclodextrins | beta-Cyclodextrins analog inhibits the reaction [Terfenadine results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 17513944 |
D047392 | beta-Cyclodextrins | beta-Cyclodextrins analog results in decreased activity of KCNH2 protein | decreases activity | 17513944 |
D001977 | Brompheniramine | Brompheniramine results in decreased activity of KCNH2 protein | decreases activity | 17010640 |
D002118 | Calcium | Nimodipine inhibits the reaction [KCNH2 protein affects the abundance of Calcium] | affects abundance|decreases reaction | 11040061 |
D002330 | Carmustine | Carmustine results in decreased expression of KCNH2 mRNA | decreases expression | 15980968 |
C016300 | chloramine-T | chloramine-T results in increased oxidation of and results in decreased activity of KCNH2 protein | decreases activity|increases oxidation | 17624316 |
D002724 | Chlorobutanol | Chlorobutanol binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 20071423 |
D002724 | Chlorobutanol | Chlorobutanol promotes the reaction [Terfenadine binds to and results in decreased activity of KCNH2 protein] | affects binding|decreases activity|increases reaction | 20071423 |
D002724 | Chlorobutanol | Terfenadine promotes the reaction [Chlorobutanol binds to and results in decreased activity of KCNH2 protein] | affects binding|decreases activity|increases reaction | 20071423 |
D020117 | Cisapride | Cisapride binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 12388285 |
D020117 | Cisapride | Cisapride results in decreased activity of KCNH2 protein | decreases activity | 14975710 |
D020117 | Cisapride | Cisapride binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 14678746 |
D020117 | Cisapride | beta-Cyclodextrins analog inhibits the reaction [Cisapride results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 17513944 |
D020117 | Cisapride | Cisapride affects the localization of KCNH2 protein mutant form | affects localization | 11741928 10531299 |
D020117 | Cisapride | Cisapride binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 15272206 11005845 12388285 |
D020117 | Cisapride | Cisapride binds to KCNH2 protein | affects binding | 18701618 19260734 |
D020117 | Cisapride | Cisapride results in decreased activity of KCNH2 protein | decreases activity | 9395068 15740727 17513944 11741928 15306208 15671647 |
D003345 | Corticosterone | Corticosterone results in increased expression of KCNH2 mRNA | increases expression | 18835572 |
C028457 | cyamemazine | cyamemazine metabolite results in decreased activity of KCNH2 protein | decreases activity | 18957172 |
C028457 | cyamemazine | cyamemazine results in decreased activity of KCNH2 protein | decreases activity | 16494862 |
C533908 | cyamemazine sulfoxide | cyamemazine sulfoxide results in decreased activity of KCNH2 protein | decreases activity | 18957172 |
C040463 | desmethylastemizole | desmethylastemizole binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 10376921 |
D004077 | Digoxin | Astemizole inhibits the reaction [Digoxin results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 19139152 |
D004077 | Digoxin | Astemizole inhibits the reaction [Digoxin results in decreased metabolism of KCNH2 protein modified form] | decreases metabolic processing|decreases reaction | 19139152 |
D004077 | Digoxin | Digoxin results in decreased activity of KCNH2 protein | decreases activity | 19139152 |
D004077 | Digoxin | Digoxin results in decreased expression of KCNH2 protein modified form | decreases expression | 19139152 |
D004077 | Digoxin | KCNH2 gene affects the susceptibility to Digoxin | affects response to substance | 19139152 |
D004077 | Digoxin | Sodium deficiency inhibits the reaction [Digoxin results in decreased expression of KCNH2 protein] | decreases expression|decreases reaction | 19139152 |
D004155 | Diphenhydramine | Diphenhydramine binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 14678746 |
D004206 | Disopyramide | Disopyramide binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 15272206 |
D004206 | Disopyramide | Disopyramide results in decreased activity of KCNH2 protein | decreases activity | 18724381 |
C063533 | dofetilide | Acids inhibits the reaction [dofetilide results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 15821840 |
C063533 | dofetilide | dofetilide binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 20071423 |
C063533 | dofetilide | dofetilide binds to KCNH2 protein | affects binding | 15272206 18701618 |
C063533 | dofetilide | dofetilide promotes the reaction [naringenin results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
C063533 | dofetilide | dofetilide results in decreased activity of KCNH2 protein | decreases activity | 10828461 16960444 18057881 9395068 15821840 17042915 |
C063533 | dofetilide | Hydrogen Peroxide inhibits the reaction [dofetilide results in decreased activity of KCNH2 protein mutant form] | decreases activity|decreases reaction | 10828461 |
C063533 | dofetilide | naringenin promotes the reaction [dofetilide results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
C063533 | dofetilide | Potassium inhibits the reaction [dofetilide results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 16960444 |
C063533 | dofetilide | [Terfenadine co-treated with dofetilide] binds to and results in decreased activity of KCNH2 protein | affects binding|affects cotreatment|decreases activity | 20071423 |
D004317 | Doxorubicin | Erythromycin affects the reaction [KCNH2 protein results in decreased susceptibility to Doxorubicin] | affects reaction|decreases response to substance | 16086867 |
D004317 | Doxorubicin | KCNH2 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 16086867 |
C118667 | dronedarone | dronedarone results in decreased activity of KCNH2 protein | decreases activity | 15618689 |
C118667 | dronedarone | Potassium inhibits the reaction [dronedarone results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 15618689 |
D004329 | Droperidol | Droperidol binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 14678746 |
C063968 | E 4031 | E 4031 results in decreased activity of KCNH2 protein | decreases activity | 14975710 |
C063968 | E 4031 | E 4031 binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 14678746 |
C063968 | E 4031 | beta-Cyclodextrins analog inhibits the reaction [E 4031 results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 17513944 |
C063968 | E 4031 | E 4031 affects the localization of KCNH2 protein mutant form | affects localization | 11741928 |
C063968 | E 4031 | E 4031 binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 15272206 |
C063968 | E 4031 | E 4031 binds to KCNH2 protein | affects binding | 19260734 |
C063968 | E 4031 | E 4031 inhibits the reaction [fexofenadine results in increased activity of KCNH2 protein mutant form] | decreases reaction|increases activity | 12070109 |
C063968 | E 4031 | E 4031 results in decreased activity of KCNH2 protein | decreases activity | 20050851 18724381 11741928 17513944 14709917 16494862 |
C063968 | E 4031 | E 4031 results in increased activity of KCNH2 protein mutant form | increases activity | 10531299 |
C063968 | E 4031 | E 4031 results in increased glycosylation of and affects the localization of KCNH2 protein mutant form | affects localization|increases glycosylation | 10531299 |
C118951 | ergotoxin, Centruroides noxius | ergotoxin, Centruroides noxius binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 20071423 |
C118951 | ergotoxin, Centruroides noxius | [Terfenadine co-treated with ergotoxin, Centruroides noxius] binds to and results in decreased activity of KCNH2 protein | affects binding|affects cotreatment|decreases activity | 20071423 |
D004917 | Erythromycin | Erythromycin affects the reaction [KCNH2 protein results in decreased susceptibility to Doxorubicin] | affects reaction|decreases response to substance | 16086867 |
D004917 | Erythromycin | Erythromycin binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 15272206 |
D004917 | Erythromycin | Erythromycin binds to KCNH2 protein | affects binding | 18701618 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of KCNH2 mRNA | affects expression | 17555576 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of KCNH2 mRNA | increases expression | 17942748 |
D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KCNH2 mRNA | affects cotreatment|increases expression | 17942748 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of KCNH2 mRNA | decreases expression | 17557909 |
C093230 | fexofenadine | E 4031 inhibits the reaction [fexofenadine results in increased activity of KCNH2 protein mutant form] | decreases reaction|increases activity | 12070109 |
C093230 | fexofenadine | fexofenadine results in increased activity of KCNH2 protein mutant form | increases activity | 12070109 |
D005419 | Flavonoids | Flavonoids results in increased expression of KCNH2 mRNA | increases expression | 18035473 |
D005424 | Flecainide | Flecainide binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 15272206 |
D005473 | Fluoxetine | Fluoxetine binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 15272206 |
D016666 | Fluvoxamine | Fluvoxamine binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 20071423 |
D016666 | Fluvoxamine | [Terfenadine co-treated with Fluvoxamine] binds to and results in decreased activity of KCNH2 protein | affects binding|affects cotreatment|decreases activity | 20071423 |
D005576 | Forskolin | [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of [ADRB1 protein binds to ADRB2 protein]] affects the reaction [KCNH2 protein results in increased transport of Potassium] | affects binding|affects cotreatment|affects reaction|increases activity|increases transport | 19419905 |
C040029 | gabapentin | gabapentin results in decreased activity of KCNH2 protein | decreases activity | 15716081 |
C001277 | geldanamycin | geldanamycin affects the localization of KCNH2 protein | affects localization | 12775586 |
C001277 | geldanamycin | geldanamycin inhibits the reaction [KCNH2 protein binds to HSP90AA1 protein] | affects binding|decreases reaction | 12775586 |
C001277 | geldanamycin | geldanamycin results in decreased activity of KCNH2 protein | decreases activity | 12775586 |
C001277 | geldanamycin | geldanamycin results in decreased expression of KCNH2 protein modified form | decreases expression | 12775586 |
C001277 | geldanamycin | geldanamycin results in increased degradation of KCNH2 protein | increases degradation | 12775586 |
C442759 | ginsenoside Rb1 | ginsenoside Rb1 affects the activity of KCNH2 protein | affects activity | 15842772 |
C055328 | ginsenoside Rf | ginsenoside Rf affects the activity of KCNH2 protein | affects activity | 15842772 |
C035054 | ginsenoside Rg1 | ginsenoside Rg1 affects the activity of KCNH2 protein | affects activity | 15842772 |
D006096 | Gramicidin | Gramicidin results in decreased expression of KCNH2 protein modified form | decreases expression | 19139152 |
D006096 | Gramicidin | Potassium inhibits the reaction [Gramicidin results in decreased expression of KCNH2 protein modified form] | decreases expression|decreases reaction | 19139152 |
D006096 | Gramicidin | Rubidium inhibits the reaction [Gramicidin results in decreased expression of KCNH2 protein modified form] | decreases expression|decreases reaction | 19139152 |
D006220 | Haloperidol | Haloperidol binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 14678746 |
D006220 | Haloperidol | Haloperidol results in decreased activity of KCNH2 protein | decreases activity | 16494862 15671647 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide inhibits the reaction [Astemizole results in decreased activity of KCNH2 protein mutant form] | decreases activity|decreases reaction | 10828461 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide inhibits the reaction [dofetilide results in decreased activity of KCNH2 protein mutant form] | decreases activity|decreases reaction | 10828461 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide inhibits the reaction [Terfenadine results in decreased activity of KCNH2 protein mutant form] | decreases activity|decreases reaction | 10828461 |
C026777 | ICI 118551 | ICI 118551 results in decreased activity of [KCNH2 protein binds to KCNH2 protein] | affects binding|decreases activity | 15679475 |
C010739 | ifenprodil | ifenprodil results in decreased activity of KCNH2 protein | decreases activity | 17460149 |
C010739 | ifenprodil | SM 21 promotes the reaction [ifenprodil results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 17460149 |
D007099 | Imipramine | Imipramine binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 15272206 |
D015056 | 1-Methyl-3-isobutylxanthine | [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of [ADRB1 protein binds to ADRB2 protein]] affects the reaction [KCNH2 protein results in increased transport of Potassium] | affects binding|affects cotreatment|affects reaction|increases activity|increases transport | 19419905 |
D007654 | Ketoconazole | Ketoconazole binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 15272206 |
D007654 | Ketoconazole | Ketoconazole results in decreased activity of KCNH2 protein | decreases activity | 9694927 |
D007654 | Ketoconazole | Terfenadine promotes the reaction [Ketoconazole results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 9694927 |
C087257 | L 706000 | L 706000 binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 12388285 |
C087257 | L 706000 | L 706000 binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 12388285 11005845 |
C047781 | lamotrigine | lamotrigine results in decreased activity of KCNH2 protein | decreases activity | 15716081 |
D017336 | Loratadine | Loratadine binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 11705456 9658196 |
D017336 | Loratadine | Loratadine results in decreased activity of KCNH2 protein | decreases activity | 10604956 |
D008628 | Mercury | Mercury results in increased expression of KCNH2 mRNA | increases expression | 16823088 |
D008653 | Mesoridazine | Mesoridazine results in decreased activity of KCNH2 protein | decreases activity | 17042915 |
C008493 | methylselenic acid | methylselenic acid results in increased expression of KCNH2 mRNA | increases expression | 18548127 |
D008790 | Metoprolol | Metoprolol results in decreased activity of [KCNH2 protein binds to KCNH2 protein] | affects binding|decreases activity | 15679475 |
C076170 | mizolastine | mizolastine results in decreased activity of KCNH2 protein | decreases activity | 11082114 |
C035359 | monorden | monorden results in decreased activity of KCNH2 protein | decreases activity | 12775586 |
C035359 | monorden | monorden results in decreased expression of KCNH2 protein modified form | decreases expression | 12775586 |
D009151 | Mustard Gas | Mustard Gas affects the expression of KCNH2 mRNA | affects expression | 15651846 |
C005273 | naringenin | Amiodarone promotes the reaction [naringenin results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
C005273 | naringenin | azimilide promotes the reaction [naringenin results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
C005273 | naringenin | dofetilide promotes the reaction [naringenin results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
C005273 | naringenin | naringenin promotes the reaction [Amiodarone results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
C005273 | naringenin | naringenin promotes the reaction [azimilide results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
C005273 | naringenin | naringenin promotes the reaction [dofetilide results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
C005273 | naringenin | naringenin promotes the reaction [Quinidine results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
C005273 | naringenin | naringenin results in decreased activity of KCNH2 protein | decreases activity | 18057881 |
C005273 | naringenin | Quinidine promotes the reaction [naringenin results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
D009553 | Nimodipine | Nimodipine inhibits the reaction [KCNH2 protein affects the abundance of Calcium] | affects abundance|decreases reaction | 11040061 |
C041094 | N,N-bis(3,4-dimethoxyphenethyl)-N-methylamine | N,N-bis(3,4-dimethoxyphenethyl)-N-methylamine binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 14678746 |
C106448 | norastemizole | norastemizole binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 10376921 |
C076029 | olanzapine | olanzapine results in decreased activity of KCNH2 protein | decreases activity | 16494862 |
D009966 | Orphenadrine | Orphenadrine binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 14678746 |
C004564 | panaxadiol | panaxadiol affects the activity of KCNH2 protein | affects activity | 15842772 |
C004563 | panaxatriol | panaxatriol affects the activity of KCNH2 protein | affects activity | 15842772 |
D010419 | Pentamidine | Pentamidine affects the localization of and affects the activity of KCNH2 protein | affects activity|affects localization | 15340016 |
D010424 | Pentobarbital | Pentobarbital results in decreased activity of KCNH2 protein | decreases activity | 11862331 |
D010480 | Perhexiline | Perhexiline binds to KCNH2 protein | affects binding | 18701618 |
D010656 | Phenylephrine | Phenylephrine affects the reaction [KCNH2 protein results in increased transport of Potassium] | affects reaction|increases transport | 19419905 |
D010868 | Pimozide | Pimozide binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 14678746 |
D010868 | Pimozide | Pimozide results in decreased activity of KCNH2 protein | decreases activity | 15671647 |
D011188 | Potassium | [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of [ADRB1 protein binds to ADRB2 protein]] affects the reaction [KCNH2 protein results in increased transport of Potassium] | affects binding|affects cotreatment|affects reaction|increases activity|increases transport | 19419905 |
D011188 | Potassium | [KCNH2 protein binds to KCNE2 protein] which results in increased transport of Potassium | affects binding|increases transport | 15679475 |
D011188 | Potassium | [KCNH2 protein binds to KCNH2 protein] which results in increased transport of Potassium | affects binding|increases transport | 15679475 |
D011188 | Potassium | KCNH2 protein results in increased transport of Potassium | increases transport | 17624316 19419905 |
D011188 | Potassium | Phenylephrine affects the reaction [KCNH2 protein results in increased transport of Potassium] | affects reaction|increases transport | 19419905 |
D011188 | Potassium | Potassium affects the stability of and affects the localization of KCNH2 protein modified form | affects localization|affects stability | 19139152 |
D011188 | Potassium | Potassium deficiency affects the folding of KCNH2 protein | affects folding | 19139152 |
D011188 | Potassium | Potassium inhibits the reaction [Amiodarone results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 15618689 |
D011188 | Potassium | Potassium inhibits the reaction [azimilide results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 16960444 |
D011188 | Potassium | Potassium inhibits the reaction [dofetilide results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 16960444 |
D011188 | Potassium | Potassium inhibits the reaction [dronedarone results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 15618689 |
D011188 | Potassium | Potassium inhibits the reaction [Gramicidin results in decreased expression of KCNH2 protein modified form] | decreases expression|decreases reaction | 19139152 |
D011188 | Potassium | Potassium inhibits the reaction [Quinidine results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 16960444 |
D011188 | Potassium | Potassium inhibits the reaction [Sotalol results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 16960444 |
D011342 | Procainamide | Procainamide binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 15272206 |
D011405 | Propafenone | Propafenone binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 14678746 |
D011405 | Propafenone | Propafenone results in decreased activity of KCNH2 protein | decreases activity | 18724381 |
D011433 | Propranolol | Propranolol results in decreased activity of [KCNH2 protein binds to KCNE2 protein] | affects binding|decreases activity | 15679475 |
D011433 | Propranolol | Propranolol results in decreased activity of [KCNH2 protein binds to KCNH2 protein] | affects binding|decreases activity | 15679475 |
C023666 | pyridine | pyridine analog binds to KCNH2 protein | affects binding | 17768047 |
D011802 | Quinidine | Acids inhibits the reaction [Quinidine results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 15821840 |
D011802 | Quinidine | KCNH2 gene SNP affects the susceptibility to Quinidine | affects response to substance | 12695533 |
D011802 | Quinidine | naringenin promotes the reaction [Quinidine results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
D011802 | Quinidine | Potassium inhibits the reaction [Quinidine results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 16960444 |
D011802 | Quinidine | Quinidine affects the localization of KCNH2 protein mutant form | affects localization | 11741928 |
D011802 | Quinidine | Quinidine binds to KCNH2 protein | affects binding | 18701618 |
D011802 | Quinidine | Quinidine promotes the reaction [naringenin results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 18057881 |
D011802 | Quinidine | Quinidine results in decreased activity of KCNH2 protein | decreases activity | 11741928 15821840 16960444 18724381 15671647 12695533 17042915 18057881 |
D011803 | Quinine | KCNH2 gene SNP affects the susceptibility to Quinine | affects response to substance | 12695533 |
D011803 | Quinine | Quinine results in decreased activity of KCNH2 protein | decreases activity | 12695533 |
D018967 | Risperidone | Risperidone results in decreased activity of KCNH2 protein | decreases activity | 14975710 |
D012413 | Rubidium | Rubidium inhibits the reaction [Gramicidin results in decreased expression of KCNH2 protein modified form] | decreases expression|decreases reaction | 19139152 |
D012503 | Saponins | Saponins affects the activity of KCNH2 protein | affects activity | 15842772 |
C107044 | SM 21 | SM 21 promotes the reaction [ifenprodil results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 17460149 |
D012964 | Sodium | Sodium deficiency inhibits the reaction [Digoxin results in decreased expression of KCNH2 protein] | decreases expression|decreases reaction | 19139152 |
D013015 | Sotalol | Potassium inhibits the reaction [Sotalol results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 16960444 |
D013015 | Sotalol | Sotalol analog binds to KCNH2 protein | affects binding | 18701618 |
D013015 | Sotalol | Sotalol results in decreased activity of KCNH2 protein | decreases activity | 16960444 |
D010042 | Ouabain | Ouabain results in decreased expression of KCNH2 protein modified form | decreases expression | 19139152 |
D013629 | Tamoxifen | Tamoxifen binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 15272206 |
D013629 | Tamoxifen | Tamoxifen affects the expression of KCNH2 mRNA | affects expression | 17555576 |
D016593 | Terfenadine | Terfenadine binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 12388285 |
D016593 | Terfenadine | Terfenadine results in decreased activity of KCNH2 protein | decreases activity | 14975710 |
D016593 | Terfenadine | Terfenadine binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 14678746 |
D016593 | Terfenadine | beta-Cyclodextrins analog inhibits the reaction [Terfenadine results in decreased activity of KCNH2 protein] | decreases activity|decreases reaction | 17513944 |
D016593 | Terfenadine | Chlorobutanol promotes the reaction [Terfenadine binds to and results in decreased activity of KCNH2 protein] | affects binding|decreases activity|increases reaction | 20071423 |
D016593 | Terfenadine | Hydrogen Peroxide inhibits the reaction [Terfenadine results in decreased activity of KCNH2 protein mutant form] | decreases activity|decreases reaction | 10828461 |
D016593 | Terfenadine | Terfenadine binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 12388285 11705456 15272206 20071423 9658196 11005845 |
D016593 | Terfenadine | Terfenadine binds to KCNH2 protein | affects binding | 18701618 19260734 |
D016593 | Terfenadine | [Terfenadine co-treated with dofetilide] binds to and results in decreased activity of KCNH2 protein | affects binding|affects cotreatment|decreases activity | 20071423 |
D016593 | Terfenadine | [Terfenadine co-treated with ergotoxin, Centruroides noxius] binds to and results in decreased activity of KCNH2 protein | affects binding|affects cotreatment|decreases activity | 20071423 |
D016593 | Terfenadine | [Terfenadine co-treated with Fluvoxamine] binds to and results in decreased activity of KCNH2 protein | affects binding|affects cotreatment|decreases activity | 20071423 |
D016593 | Terfenadine | Terfenadine promotes the reaction [Chlorobutanol binds to and results in decreased activity of KCNH2 protein] | affects binding|decreases activity|increases reaction | 20071423 |
D016593 | Terfenadine | Terfenadine promotes the reaction [Ketoconazole results in decreased activity of KCNH2 protein] | decreases activity|increases reaction | 9694927 |
D016593 | Terfenadine | Terfenadine results in decreased activity of KCNH2 protein | decreases activity | 12070109 19915712 15740727 10828461 10604956 10422790 8641472 15671647 17513944 8772706 17042915 16931984 14709917 9395068 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of KCNH2 mRNA | increases expression | 20055451 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KCNH2 mRNA | affects cotreatment|increases expression | 17942748 |
D013881 | Thioridazine | Thioridazine binds to and results in decreased activity of KCNH2 protein | affects binding|decreases activity | 14678746 |
D013881 | Thioridazine | Thioridazine results in decreased activity of KCNH2 protein | decreases activity | 15671647 |
C052342 | topiramate | topiramate results in decreased activity of KCNH2 protein | decreases activity | 15716081 |
D014196 | Trazodone | Trazodone results in decreased activity of KCNH2 protein | decreases activity | 15740727 |
D014700 | Verapamil | Verapamil results in decreased activity of KCNH2 protein | decreases activity | 14975710 |
D014700 | Verapamil | Verapamil results in decreased activity of KCNH2 protein | decreases activity | 15671647 |
C041667 | vesnarinone | KCNH2 gene SNP affects the susceptibility to vesnarinone | affects response to substance | 12695533 |
C041667 | vesnarinone | vesnarinone results in decreased activity of KCNH2 protein | decreases activity | 12695533 |
D014810 | Vitamin E | Vitamin E results in increased expression of KCNH2 mRNA | increases expression | 19244175 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 3.67 | 14745880 | |
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 2.02 | 15322242 14514962 11752688 | |
MESH:D000138 | Acidosis | Ammonium Chloride | 2.70 | 18287403 | |
MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 3.07 | 17505938 | |
MESH:D000230 | Adenocarcinoma | arsenic trioxide | 5.21 | 11798837 19825857 | |
MESH:D000230 | Adenocarcinoma | Doxorubicin | 5.21 | 17418594 | |
MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 5.21 | 14692618 | |
MESH:D000236 | Adenoma | 4,4'-diaminodiphenylmethane | 2.19 | 3712494 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 2.52 | 16835633 | |
MESH:D018246 | Adrenocortical Adenoma | Arsenic | 4.33 | 17306315 | |
MESH:D017088 | AIDS-Related Opportunistic Infections | Pentamidine | 5.49 | 11806628 | |
MESH:D000419 | Albuminuria | Doxorubicin | 3.72 | 21441931 | |
MESH:D000437 | Alcoholism | topiramate | 4.33 | 19331489 17925516 18552399 | |
OMIM:607154 | ALLERGIC RHINITIS | fexofenadine | 13.14 | 16037679 | |
OMIM:607154 | ALLERGIC RHINITIS | Loratadine | 13.14 | 16527031 | |
OMIM:607154 | ALLERGIC RHINITIS | Terfenadine | 13.14 | 16037679 | |
MESH:D000544 | Alzheimer Disease | Trazodone | 3.57 | 17897735 16856516 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.19 | 11748828 | |
MESH:D000799 | Angioedema | Astemizole | 4.78 | 2883202 | |
MESH:D001008 | Anxiety Disorders | Fluoxetine | 7.38 | 18083778 | |
MESH:D001008 | Anxiety Disorders | Pentobarbital | 7.38 | 11141031 18313124 | |
MESH:D001145 | Arrhythmias, Cardiac | marker/mechanism | 14678746 18250272 | ||
MESH:D001145 | Arrhythmias, Cardiac | Amiodarone | 46.76 | 18057881 20041841 18218290 | |
MESH:D001145 | Arrhythmias, Cardiac | azimilide | 46.76 | 18057881 18651412 | |
MESH:D001145 | Arrhythmias, Cardiac | dofetilide | 46.76 | 18651412 18057881 | |
MESH:D001145 | Arrhythmias, Cardiac | dronedarone | 46.76 | 18651412 | |
MESH:D001145 | Arrhythmias, Cardiac | E 4031 | 46.76 | 18724381 | |
MESH:D001145 | Arrhythmias, Cardiac | ifenprodil | 46.76 | 17460149 | |
MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 46.76 | 17460149 | |
MESH:D001145 | Arrhythmias, Cardiac | Propafenone | 46.76 | 16882315 | |
MESH:D001145 | Arrhythmias, Cardiac | Quinidine | 46.76 | 18057881 18724381 | |
MESH:D001145 | Arrhythmias, Cardiac | Sotalol | 46.76 | 18724381 | |
MESH:D020261 | Arsenic Poisoning | Arsenic | 2.54 | 18414634 12569548 16251483 16835338 | |
MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 2.63 | 11256880 | |
MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 2.07 | 15885639 | |
MESH:D020817 | Asperger Syndrome | Risperidone | 4.73 | 16401163 | |
MESH:D001249 | Asthma | Loratadine | 4.46 | 9196086 | |
MESH:D001249 | Asthma | Mustard Gas | 4.46 | 10378619 | |
MESH:D050197 | Atherosclerosis | Arsenic | 5.62 | 12928151 19371607 | |
MESH:D050197 | Atherosclerosis | Saponins | 5.62 | 18637019 | |
MESH:D001281 | Atrial Fibrillation | Amiodarone | 7.92 | 19698954 18651412 | |
MESH:D001281 | Atrial Fibrillation | dronedarone | 7.92 | 17804843 | |
MESH:D001289 | Attention Deficit Disorder with Hyperactivity | Risperidone | 4.15 | 18349709 | |
MESH:D001321 | Autistic Disorder | Digoxin | 5.70 | 14585753 | |
MESH:D001321 | Autistic Disorder | Fluoxetine | 5.70 | 18775368 19232924 | |
MESH:D001321 | Autistic Disorder | Fluvoxamine | 5.70 | 18775368 19232924 12607287 | |
MESH:D001321 | Autistic Disorder | Haloperidol | 5.70 | 18080171 19368416 | |
MESH:D001321 | Autistic Disorder | Mercury | 5.70 | 17497416 | |
MESH:D001321 | Autistic Disorder | olanzapine | 5.70 | 18685284 17069543 | |
MESH:D001321 | Autistic Disorder | Propranolol | 5.70 | 18766980 | |
MESH:D001321 | Autistic Disorder | Risperidone | 5.70 | 18080171 17069546 19232924 16239862 18775368 18026891 16601648 19368416 15994720 19013209 15492353 16379507 18278980 17019624 18349709 19154706 17929164 15930063 15543515 16730335 16948927 | |
MESH:D001327 | Autoimmune Diseases | Mercury | 4.03 | 16634805 | |
MESH:D001660 | Biliary Tract Diseases | 4,4'-diaminodiphenylmethane | 4.14 | 11289319 1440618 | |
MESH:D001714 | Bipolar Disorder | Risperidone | 4.00 | 19154706 18278980 | |
MESH:D001768 | Blister | Mustard Gas | 4.29 | 19167455 | |
MESH:D001778 | Blood Coagulation Disorders | Amiodarone | 10.86 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 10.86 | 16206674 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 10.86 | 12125929 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.91 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.15 | 15746008 | |
MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 3.82 | 14601052 | |
MESH:D001919 | Bradycardia | Phenylephrine | 8.25 | 15306635 | |
MESH:D001919 | Bradycardia | Propranolol | 8.25 | 6740701 | |
MESH:D001932 | Brain Neoplasms | Carmustine | 6.60 | 16187019 | |
MESH:D001932 | Brain Neoplasms | Doxorubicin | 6.60 | 17150277 | |
MESH:D001943 | Breast Neoplasms | Doxorubicin | 2.01 | 16096432 16115903 15939500 11325840 19526202 16322301 18628466 15668708 16264153 15634643 18695136 16595493 15136595 15692762 17983394 17426702 18382427 16826403 15567936 17369602 15993339 15994142 16935488 18234424 | |
MESH:D001943 | Breast Neoplasms | Tamoxifen | 2.01 | 19103187 17893378 19059307 20135344 19487384 19155303 16818667 19084267 18425577 18815881 19244106 18855134 19289846 19189210 17049068 15565566 19066611 17261762 18821012 11161223 18997820 15668708 18984771 19221464 19200415 20544844 16873071 20390343 16273361 19011961 20065188 19115204 18351453 16202921 21152245 18629630 20859285 19142967 17242785 19189212 20005174 19288272 17440819 19410462 21138602 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 2.01 | 20435547 | |
MESH:D001989 | Bronchiolitis Obliterans | Mustard Gas | 4.29 | 15286001 | |
MESH:D029481 | Bronchitis, Chronic | Mustard Gas | 4.10 | 17687719 10378619 | |
MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 3.52 | 11589617 | |
MESH:D002252 | Carbon Tetrachloride Poisoning | Vitamin E | 3.09 | 16050911 | |
MESH:D002276 | Carcinoid Tumor | Doxorubicin | 3.93 | 16051944 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 2.09 | 16835633 | |
MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 3.03 | 15504454 17687452 | |
MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.66 | 19066611 | |
MESH:D006528 | Carcinoma, Hepatocellular | 4,4'-diaminodiphenylmethane | 8.41 | 3581430 7296757 | |
MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 8.41 | 16507464 17306315 | |
MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 8.41 | 14691202 15073043 16217749 15553829 11135700 | |
MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 8.41 | 18059187 17876044 16234567 16023760 | |
MESH:D006528 | Carcinoma, Hepatocellular | pyridine | 8.41 | 10696769 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 8.41 | 16924424 | |
MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.99 | 19014326 | |
MESH:D002292 | Carcinoma, Renal Cell | 4,4'-diaminodiphenylmethane | 4.88 | 7296757 | |
MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 4.88 | 16201981 1485588 | |
MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 3.35 | 12490120 | |
MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 3.77 | 17687452 18922899 15504454 | |
MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 3.77 | 6189445 | |
MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 6.96 | 18640142 | |
MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 6.96 | 17572228 | |
MESH:D006332 | Cardiomegaly | Phenylephrine | 5.02 | 15728586 11179087 17124262 11754973 17287366 16170337 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 5.02 | 18670907 18850075 16120746 | |
MESH:D009202 | Cardiomyopathies | Doxorubicin | 2.91 | 16952015 16731534 16242529 16109756 17974986 17131338 16278810 17308081 17007740 16651473 16455267 16269455 16612575 17329180 17928571 17351982 17924179 15505089 15792986 17519947 15811867 15476868 17382496 18627295 16364871 | |
MESH:D002311 | Cardiomyopathy, Dilated | Amiodarone | 10.36 | 15710769 19225199 | |
MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 10.36 | 17334414 16243910 | |
MESH:D002311 | Cardiomyopathy, Dilated | Mercury | 10.36 | 10334427 | |
MESH:D002311 | Cardiomyopathy, Dilated | Metoprolol | 10.36 | 19477965 | |
MESH:D002318 | Cardiovascular Diseases | Arsenic | 5.43 | 15738583 17938729 19152805 | |
MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 5.43 | 16936243 | |
MESH:D002340 | Carotid Artery Diseases | Arsenic | 3.56 | 16973168 18022660 | |
MESH:D002341 | Carotid Artery Thrombosis | Amiodarone | 4.22 | 18974383 | |
MESH:D002375 | Catalepsy | Haloperidol | 9.21 | 1977408 15215559 | |
MESH:D002375 | Catalepsy | Pimozide | 9.21 | 1977408 | |
MESH:D002389 | Catatonia | olanzapine | 5.37 | 18071103 16772815 | |
MESH:D002471 | Cell Transformation, Neoplastic | 4,4'-diaminodiphenylmethane | 2.14 | 7505956 | |
MESH:D002637 | Chest Pain | Acids | 10.19 | 15447763 | |
MESH:D002637 | Chest Pain | Trazodone | 10.19 | 15238202 | |
MESH:D002659 | Child Development Disorders, Pervasive | topiramate | 3.70 | 15650499 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 2.41 | 16835633 | |
MESH:D002779 | Cholestasis | 4,4'-diaminodiphenylmethane | 5.60 | 19486331 9022650 | |
MESH:D002779 | Cholestasis | Ethinyl Estradiol | 5.60 | 15861022 16105132 17333356 17681005 17110522 16919318 11677210 | |
MESH:D016770 | Ciliophora Infections | Quinine | 4.91 | 12113305 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 1.67 | 15340226 15668235 8697196 12621046 16354765 | |
MESH:D003110 | Colonic Neoplasms | marker/mechanism | 16086867 | ||
MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 2.30 | 20501625 | |
MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 2.30 | 18259882 18802399 | |
MESH:D003128 | Coma | Trazodone | 5.25 | 10836866 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 2.31 | 17141729 14669216 | |
MESH:D023903 | Coronary Restenosis | arsenic trioxide | 3.36 | 12609071 | |
MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 2.91 | 10525206 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 2.91 | 10048152 20055451 15322242 | |
MESH:D019465 | Craniofacial Abnormalities | Vitamin E | 2.91 | 19769572 | |
MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 19.50 | 15213294 | |
MESH:D016757 | Death, Sudden, Cardiac | Haloperidol | 19.50 | 20210726 | |
MESH:D016757 | Death, Sudden, Cardiac | Risperidone | 19.50 | 20210726 | |
MESH:D016757 | Death, Sudden, Cardiac | Thioridazine | 19.50 | 20210726 | |
MESH:D003704 | Dementia | Haloperidol | 17.29 | 11575062 | |
MESH:D003704 | Dementia | Risperidone | 17.29 | 11575062 | |
MESH:D003704 | Dementia | Thioridazine | 17.29 | 11575062 | |
MESH:D003704 | Dementia | Trazodone | 17.29 | 11575062 12587811 | |
MESH:D003711 | Demyelinating Diseases | Tamoxifen | 3.52 | 19031437 | |
MESH:D003866 | Depressive Disorder | Fluoxetine | 13.20 | 15014590 | |
MESH:D003866 | Depressive Disorder | Fluvoxamine | 13.20 | 19571598 | |
MESH:D003866 | Depressive Disorder | Imipramine | 13.20 | 20305041 | |
MESH:D003866 | Depressive Disorder | Trazodone | 13.20 | 19623435 18083778 20305041 3690436 4066620 15014590 3378227 | |
MESH:D003865 | Depressive Disorder, Major | Fluvoxamine | 8.61 | 17474826 | |
MESH:D003865 | Depressive Disorder, Major | Trazodone | 8.61 | 16968574 | |
MESH:D017449 | Dermatitis, Allergic Contact | 4,4'-diaminodiphenylmethane | 4.51 | 12868966 11906362 18759878 2524372 8156756 14531868 8970840 11298694 | |
MESH:D017449 | Dermatitis, Allergic Contact | Mercury | 4.51 | 16823706 | |
MESH:D003876 | Dermatitis, Atopic | fexofenadine | 4.29 | 17133778 | |
MESH:D003877 | Dermatitis, Contact | 4,4'-diaminodiphenylmethane | 2.70 | 2952479 3621924 | |
MESH:D002658 | Developmental Disabilities | olanzapine | 4.06 | 17069543 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 3.74 | 17107852 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | topiramate | 3.74 | 16979414 | |
MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 2.73 | 19279558 | |
MESH:D006970 | Disorders of Excessive Somnolence | Risperidone | 5.45 | 16379507 | |
MESH:D053207 | Diurnal Enuresis | Risperidone | 5.79 | 17822346 | |
MESH:D004244 | Dizziness | Astemizole | 5.58 | 3105558 | |
MESH:D004314 | Down Syndrome | Risperidone | 4.40 | 18349709 | |
MESH:D056486 | Drug-Induced Liver Injury | 4,4'-diaminodiphenylmethane | 8.18 | 18289764 18648102 18692083 7440962 9022650 6482804 8291058 9328219 9653073 6679447 11289319 1440618 16192314 | |
MESH:D056486 | Drug-Induced Liver Injury | Amiodarone | 8.18 | 15265979 18218290 | |
MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 8.18 | 17416283 | |
MESH:D056486 | Drug-Induced Liver Injury | Ketoconazole | 8.18 | 18289764 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 8.18 | 20420201 | |
MESH:D004362 | Drug Toxicity | Doxorubicin | 5.84 | 18602426 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 5.84 | 11462148 | |
MESH:D004409 | Dyskinesia, Drug-Induced | Trazodone | 5.05 | 3690436 | |
MESH:D004421 | Dystonia | Trazodone | 4.83 | 3700695 | |
MESH:C538011 | Eales disease | Vitamin E | 3.82 | 9068938 | |
MESH:D004487 | Edema | Fluoxetine | 13.61 | 12798668 | |
MESH:D004487 | Edema | Imipramine | 13.61 | 12798668 | |
MESH:D004487 | Edema | Mustard Gas | 13.61 | 11402378 9260866 11428647 11428631 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 13.61 | 12711302 11000095 | |
MESH:D004487 | Edema | Trazodone | 13.61 | 12798668 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 3.02 | 18230668 15322242 16714409 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 6.23 | 12538720 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 6.23 | 19031437 | |
MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 5.48 | 17359293 | |
MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 5.48 | 19155303 20544844 16202921 17893378 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 2.26 | 9294722 10568697 | |
MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 4.28 | 18037988 | |
MESH:D004802 | Eosinophilia | Astemizole | 3.98 | 1355641 | |
MESH:D004816 | Epidermal Necrolysis, Toxic | lamotrigine | 5.32 | 20235791 | |
MESH:D004831 | Epilepsies, Myoclonic | gabapentin | 9.55 | 3659116 | |
MESH:D004831 | Epilepsies, Myoclonic | lamotrigine | 9.55 | 17275665 | |
MESH:D004828 | Epilepsies, Partial | lamotrigine | 5.00 | 17116037 | |
MESH:D004827 | Epilepsy | lamotrigine | 6.14 | 19668019 | |
MESH:D004827 | Epilepsy | topiramate | 6.14 | 19148780 | |
MESH:D004833 | Epilepsy, Temporal Lobe | lamotrigine | 11.98 | 16499746 | |
MESH:D004833 | Epilepsy, Temporal Lobe | topiramate | 11.98 | 16499746 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | gabapentin | 5.45 | 3659116 | |
MESH:D007172 | Erectile Dysfunction | Trazodone | 4.66 | 7604472 | |
MESH:D004890 | Erythema | Mustard Gas | 4.29 | 9357497 | |
MESH:D004916 | Erythromelalgia | gabapentin | 6.04 | 19549232 | |
MESH:D004938 | Esophageal Neoplasms | 4,4'-diaminodiphenylmethane | 3.41 | 3581430 | |
MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 3.41 | 12903497 | |
MESH:D020329 | Essential Tremor | Trazodone | 5.25 | 3296121 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 2.33 | 11564622 | |
MESH:D005234 | Fatty Liver | Amiodarone | 12.44 | 14986274 | |
MESH:D005234 | Fatty Liver | arsenic trioxide | 12.44 | 15073043 | |
MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 12.44 | 15345470 | |
MESH:D005234 | Fatty Liver | Tamoxifen | 12.44 | 14986274 19224547 | |
MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 2.64 | 16709447 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.62 | 11858732 | |
MESH:D005350 | Fibroma | 4,4'-diaminodiphenylmethane | 4.14 | 6705139 | |
MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 3.66 | 14745880 | |
MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 8.58 | 19069698 | |
MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 8.58 | 19069698 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 2.13 | 20067830 | |
MESH:D005393 | Fish Diseases | Quinine | 4.88 | 12113305 | |
MESH:D005499 | Folliculitis | Astemizole | 5.04 | 1671328 | |
MESH:D005534 | Foot Diseases | Arsenic | 4.68 | 6392382 | |
MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 3.44 | 16904648 | |
MESH:D005909 | Glioblastoma | Carmustine | 5.51 | 16187019 | |
MESH:D005909 | Glioblastoma | Doxorubicin | 5.51 | 17150277 | |
MESH:D006042 | Goiter | 4,4'-diaminodiphenylmethane | 3.23 | 7505956 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.71 | 10696789 | |
MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 2.90 | 15692506 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 4.77 | 10048152 11294989 | |
MESH:D006330 | Heart Defects, Congenital | Vitamin E | 4.77 | 16080930 | |
MESH:D006331 | Heart Diseases | Doxorubicin | 2.84 | 16495754 18674790 17875725 16707910 18006777 16144979 14766674 16330681 16244372 12587719 16879835 16244371 17888722 | |
MESH:D006333 | Heart Failure | Doxorubicin | 5.82 | 17481944 | |
MESH:D006333 | Heart Failure | Propranolol | 5.82 | 20082655 | |
MESH:D006394 | Hemangiosarcoma | Doxorubicin | 3.12 | 15692506 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.55 | 11000095 | |
MESH:D006505 | Hepatitis | 4,4'-diaminodiphenylmethane | 2.70 | 6705139 | |
MESH:D006529 | Hepatomegaly | Amiodarone | 9.88 | 15265979 | |
MESH:D006529 | Hepatomegaly | Propranolol | 9.88 | 16371745 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 9.88 | 12621046 15340226 16120746 | |
MESH:D006548 | Hernia, Diaphragmatic | Vitamin E | 2.32 | 16490937 16863852 | |
MESH:D006561 | Herpes Simplex | Amsacrine | 4.79 | 10809021 | |
MESH:D006689 | Hodgkin Disease | Doxorubicin | 2.70 | 18501091 17606976 15147373 | |
MESH:D019584 | Hot Flashes | Fluoxetine | 17.47 | 14716179 | |
MESH:D019584 | Hot Flashes | gabapentin | 17.47 | 14716179 | |
MESH:D019584 | Hot Flashes | Trazodone | 17.47 | 19711746 | |
MESH:D019584 | Hot Flashes | Vitamin E | 17.47 | 14716179 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.17 | 16354765 15340226 16959395 8697196 18606429 | |
MESH:D006930 | Hyperalgesia | Trazodone | 4.18 | 12790215 | |
MESH:D006937 | Hypercholesterolemia | Amiodarone | 3.10 | 8137927 9751232 | |
MESH:D006943 | Hyperglycemia | Risperidone | 4.40 | 18278980 | |
MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 3.68 | 17050553 | |
MESH:D006963 | Hyperphagia | olanzapine | 5.36 | 17933447 | |
MESH:D006965 | Hyperplasia | 4,4'-diaminodiphenylmethane | 3.10 | 15034207 | |
MESH:D006967 | Hypersensitivity | fexofenadine | 7.42 | 17910814 | |
MESH:D006967 | Hypersensitivity | Terfenadine | 7.42 | 2570798 | |
MESH:D006973 | Hypertension | Arsenic | 11.85 | 16076760 11953799 9931084 | |
MESH:D006973 | Hypertension | Ouabain | 11.85 | 18976649 | |
MESH:D006973 | Hypertension | Phenylephrine | 11.85 | 12717712 8949925 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 11.85 | 18670907 18850075 | |
MESH:D006973 | Hypertension | Verapamil | 11.85 | 17700361 | |
MESH:D006984 | Hypertrophy | Phenylephrine | 3.77 | 12791704 18502941 | |
MESH:D006987 | Hypesthesia | Arsenic | 4.68 | 16093927 | |
MESH:D020514 | Hypokalemic Periodic Paralysis | Potassium | 5.00 | 19822448 | |
MESH:D007021 | Hypospadias | Ethinyl Estradiol | 9.00 | 16945680 16569931 | |
MESH:D007021 | Hypospadias | Loratadine | 9.00 | 16407038 | |
MESH:D007022 | Hypotension | Propranolol | 4.39 | 6740701 | |
MESH:D007024 | Hypotension, Orthostatic | Trazodone | 5.14 | 15811171 | |
MESH:D007037 | Hypothyroidism | Amiodarone | 3.67 | 17991464 18020914 | |
MESH:D007077 | Ileal Diseases | 1-Methyl-3-isobutylxanthine | 4.56 | 18306037 | |
MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 2.66 | 12013081 | |
MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 1.88 | 17937319 | |
MESH:D007249 | Inflammation | Erythromycin | 19.23 | 19502290 | |
MESH:D007249 | Inflammation | Flavonoids | 19.23 | 17296493 | |
MESH:D007249 | Inflammation | Fluoxetine | 19.23 | 12798668 | |
MESH:D007249 | Inflammation | Imipramine | 19.23 | 12798668 | |
MESH:D007249 | Inflammation | Mustard Gas | 19.23 | 8975870 11402378 17524151 11428647 9260866 11428631 11428620 16001271 9357497 | |
MESH:D007249 | Inflammation | Tamoxifen | 19.23 | 19457130 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 19.23 | 12878042 12200463 | |
MESH:D007249 | Inflammation | Trazodone | 19.23 | 12798668 | |
MESH:D007251 | Influenza, Human | Vitamin E | 3.34 | 16624496 | |
MESH:D007565 | Jaundice | 4,4'-diaminodiphenylmethane | 4.14 | 8074119 9022650 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 2.55 | 16580747 | |
MESH:D007579 | Jejunal Diseases | 1-Methyl-3-isobutylxanthine | 4.56 | 18306037 | |
MESH:D007642 | Keratosis | Arsenic | 4.13 | 16930632 12749816 | |
MESH:D007674 | Kidney Diseases | Doxorubicin | 6.97 | 15369732 15699352 16775033 | |
MESH:D007674 | Kidney Diseases | Mercury | 6.97 | 17934191 | |
MESH:D007674 | Kidney Diseases | Vitamin E | 6.97 | 12488133 | |
MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 7.52 | 16707910 | |
MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 7.52 | 16518626 | |
MESH:D007680 | Kidney Neoplasms | 4,4'-diaminodiphenylmethane | 8.52 | 6582329 | |
MESH:D007680 | Kidney Neoplasms | pyridine | 8.52 | 10696769 | |
MESH:D007680 | Kidney Neoplasms | Tamoxifen | 8.52 | 18625569 | |
MESH:D007683 | Kidney Tubular Necrosis, Acute | Calcium | 4.17 | 16316344 | |
MESH:D007896 | Leishmaniasis | Pentamidine | 4.65 | 15340016 | |
MESH:D016773 | Leishmaniasis, Cutaneous | Ketoconazole | 7.04 | 1311351 2166429 8889330 19744259 | |
MESH:D016773 | Leishmaniasis, Cutaneous | Pentamidine | 7.04 | 12453009 8889330 10617787 11806628 | |
MESH:D007897 | Leishmaniasis, Mucocutaneous | Pentamidine | 5.21 | 10881086 | |
MESH:D007898 | Leishmaniasis, Visceral | Ketoconazole | 6.64 | 11332679 | |
MESH:D007898 | Leishmaniasis, Visceral | Pentamidine | 6.64 | 1659303 7715298 10467834 12803856 7498017 16131481 | |
MESH:D007938 | Leukemia | arsenic trioxide | 2.33 | 15070760 | |
MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 4.28 | 16085563 | |
MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 3.01 | 17077332 12560223 | |
MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 3.45 | 16972261 | |
MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 2.75 | 14633726 | |
MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 2.98 | 19077051 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Amsacrine | 3.77 | 18043129 15148258 | |
MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 3.77 | 16467208 16968895 20471514 17050201 19850784 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 5.69 | 17339181 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 5.69 | 19035177 12018890 16891316 15336539 16823087 17217047 17712046 12679006 15213294 16330433 9834237 15748426 11161223 15622746 19642359 16331271 17107899 19225113 11468182 16966277 12712474 17869043 16112521 17649720 19075265 | |
MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 3.53 | 16882451 | |
MESH:D017513 | Lichen Nitidus | Astemizole | 5.58 | 2563723 | |
MESH:D008064 | Lipidoses | Amiodarone | 31.55 | 17567588 15342952 | |
MESH:D008064 | Lipidoses | Fluoxetine | 31.55 | 15342952 17567588 | |
MESH:D008064 | Lipidoses | Imipramine | 31.55 | 17567588 15342952 | |
MESH:D008064 | Lipidoses | Ketoconazole | 31.55 | 17567588 | |
MESH:D008064 | Lipidoses | Loratadine | 31.55 | 17567588 | |
MESH:D008064 | Lipidoses | Perhexiline | 31.55 | 15342952 17567588 | |
MESH:D008064 | Lipidoses | Tamoxifen | 31.55 | 15342952 17567588 | |
MESH:D008064 | Lipidoses | Thioridazine | 31.55 | 17567588 15342952 | |
MESH:D008105 | Liver Cirrhosis, Biliary | 4,4'-diaminodiphenylmethane | 2.59 | 9327722 15034207 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 4.89 | 16439617 16595196 | |
MESH:D008106 | Liver Cirrhosis, Experimental | naringenin | 4.89 | 14709902 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 4.89 | 18564211 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 4.89 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin E | 4.89 | 16169303 | |
MESH:D008107 | Liver Diseases | Arsenic | 3.89 | 11134558 | |
MESH:D008107 | Liver Diseases | naringenin | 3.89 | 16945181 | |
MESH:D017114 | Liver Failure, Acute | Trazodone | 4.65 | 19857765 | |
MESH:D008113 | Liver Neoplasms | Arsenic | 7.18 | 16368122 | |
MESH:D008113 | Liver Neoplasms | arsenic trioxide | 7.18 | 14682389 | |
MESH:D008113 | Liver Neoplasms | Tamoxifen | 7.18 | 16684651 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 7.18 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | 4,4'-diaminodiphenylmethane | 9.18 | 598648 1399818 6587162 3712494 | |
MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 9.18 | 20377131 | |
MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 9.18 | 17085340 16842330 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 9.18 | 12151625 | |
MESH:D008133 | Long QT Syndrome | marker/mechanism | 11741928 17467628 15213294 12070109 | ||
MESH:D008133 | Long QT Syndrome | Amiodarone | 53.87 | 15350150 17391786 11989578 | |
MESH:D008133 | Long QT Syndrome | arsenic trioxide | 53.87 | 15213294 | |
MESH:D008133 | Long QT Syndrome | Astemizole | 53.87 | 18472280 11989578 | |
MESH:D008133 | Long QT Syndrome | Cisapride | 53.87 | 18472280 | |
MESH:D008133 | Long QT Syndrome | Droperidol | 53.87 | 20210726 | |
MESH:D008133 | Long QT Syndrome | Metoprolol | 53.87 | 19353679 | |
MESH:D008133 | Long QT Syndrome | olanzapine | 53.87 | 20210726 | |
MESH:D008133 | Long QT Syndrome | Quinidine | 53.87 | 11989578 15350150 | |
MESH:D008133 | Long QT Syndrome | Sotalol | 53.87 | 15350150 11989578 | |
MESH:D008133 | Long QT Syndrome | Terfenadine | 53.87 | 8772706 | |
MESH:D008133 | Long QT Syndrome | Thioridazine | 53.87 | 20210726 | |
MESH:D008133 | Long QT Syndrome | Trazodone | 53.87 | 18167038 | |
MESH:D008171 | Lung Diseases | Amiodarone | 8.71 | 12587719 | |
MESH:D008171 | Lung Diseases | Mustard Gas | 8.71 | 18702808 18161513 | |
MESH:D008171 | Lung Diseases | Vitamin E | 8.71 | 16863852 | |
MESH:D017563 | Lung Diseases, Interstitial | Amiodarone | 3.60 | 18516814 | |
MESH:D008175 | Lung Neoplasms | Arsenic | 7.89 | 17306315 17976673 19168569 | |
MESH:D008175 | Lung Neoplasms | arsenic trioxide | 7.89 | 19825857 11798837 | |
MESH:D008175 | Lung Neoplasms | Doxorubicin | 7.89 | 6189445 17418594 | |
MESH:D008175 | Lung Neoplasms | Mustard Gas | 7.89 | 3148597 8781369 | |
MESH:D008175 | Lung Neoplasms | Tamoxifen | 7.89 | 18625569 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 7.89 | 11884234 19555203 | |
MESH:D008175 | Lung Neoplasms | Vitamin E | 7.89 | 11062179 | |
MESH:D008223 | Lymphoma | Doxorubicin | 2.81 | 16098063 | |
MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 3.07 | 17654614 | |
MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 3.72 | 15621674 | |
MESH:D008288 | Malaria | Astemizole | 7.96 | 16816845 | |
MESH:D008288 | Malaria | desmethylastemizole | 7.96 | 16816845 | |
MESH:D016778 | Malaria, Falciparum | Perhexiline | 13.61 | 16882315 | |
MESH:D016778 | Malaria, Falciparum | Propafenone | 13.61 | 16882315 | |
MESH:D016778 | Malaria, Falciparum | Thioridazine | 13.61 | 16882315 | |
MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 2.91 | 19428831 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Corticosterone | 6.60 | 12807724 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 6.60 | 15458769 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 6.60 | 16827153 11731420 19196722 14580682 19196723 | |
MESH:D020149 | Manganese Poisoning | Tamoxifen | 3.67 | 19453300 | |
MESH:D008545 | Melanoma | Carmustine | 3.88 | 12393984 | |
MESH:D008545 | Melanoma | Doxorubicin | 3.88 | 16827129 | |
MESH:D008545 | Melanoma | Tamoxifen | 3.88 | 12393984 19393235 | |
MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 3.32 | 15990972 | |
MESH:D001523 | Mental Disorders | Fluoxetine | 32.62 | 16856516 | |
MESH:D001523 | Mental Disorders | Fluvoxamine | 32.62 | 16856516 | |
MESH:D001523 | Mental Disorders | Haloperidol | 32.62 | 16856516 | |
MESH:D001523 | Mental Disorders | Imipramine | 32.62 | 16856516 | |
MESH:D001523 | Mental Disorders | olanzapine | 32.62 | 16856516 | |
MESH:D001523 | Mental Disorders | Pimozide | 32.62 | 16856516 | |
MESH:D001523 | Mental Disorders | Risperidone | 32.62 | 16856516 16596465 | |
MESH:D001523 | Mental Disorders | Thioridazine | 32.62 | 16856516 | |
MESH:D001523 | Mental Disorders | Trazodone | 32.62 | 16856516 | |
MESH:D008607 | Mental Retardation | Risperidone | 3.73 | 18349709 | |
MESH:D008654 | Mesothelioma | Doxorubicin | 2.63 | 17638057 | |
MESH:D008659 | Metabolic Diseases | olanzapine | 4.60 | 19142110 | |
MESH:D024821 | Metabolic Syndrome X | Risperidone | 4.45 | 19142101 | |
MESH:D008881 | Migraine Disorders | gabapentin | 6.67 | 18803445 18759728 | |
MESH:D008881 | Migraine Disorders | topiramate | 6.67 | 18803445 16942474 18765137 18759728 | |
MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.71 | 15792986 | |
MESH:D019964 | Mood Disorders | Risperidone | 4.99 | 17019624 | |
MESH:D009069 | Movement Disorders | Trazodone | 4.96 | 4066620 | |
MESH:D052016 | Mucositis | Doxorubicin | 3.93 | 17415656 | |
MESH:D009101 | Multiple Myeloma | arsenic trioxide | 2.46 | 11468182 19417148 14977855 15949261 19549372 | |
MESH:D009103 | Multiple Sclerosis | 4-Aminopyridine | 5.01 | 19915712 | |
MESH:D009133 | Muscular Atrophy | marker/mechanism | 16723379 | ||
MESH:D009181 | Mycoses | Amiodarone | 4.02 | 12754197 17974566 | |
MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.79 | 18349030 | |
MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 2.58 | 16882451 16105982 | |
MESH:D009203 | Myocardial Infarction | Doxorubicin | 5.14 | 15857846 19429709 | |
MESH:D009203 | Myocardial Infarction | Metoprolol | 5.14 | 18072171 | |
MESH:D017202 | Myocardial Ischemia | Arsenic | 6.62 | 15371236 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 6.62 | 12213967 | |
MESH:D009207 | Myoclonus | Fluoxetine | 5.01 | 8041377 | |
MESH:D009224 | Myotonia Congenita | Quinine | 5.38 | 1896199 | |
MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 3.14 | 16624393 | |
MESH:D009362 | Neoplasm Metastasis | 4,4'-diaminodiphenylmethane | 6.90 | 3581430 | |
MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 6.90 | 18259882 | |
MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 6.90 | 19393235 | |
MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 2.15 | 19410462 | |
MESH:D009369 | Neoplasms | naringenin | 3.78 | 15185748 | |
MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 3.13 | 19189210 19196722 19200415 | |
MESH:D009401 | Nephrosis | Doxorubicin | 3.92 | 16636307 16899518 | |
MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 3.25 | 15640375 16889571 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 2.40 | 14600291 | |
MESH:D009436 | Neural Tube Defects | 4,4'-diaminodiphenylmethane | 8.55 | 6679447 | |
MESH:D009436 | Neural Tube Defects | Arsenic | 8.55 | 16620997 | |
MESH:D009436 | Neural Tube Defects | arsenic trioxide | 8.55 | 10525206 | |
MESH:D009447 | Neuroblastoma | Doxorubicin | 2.74 | 15555623 | |
MESH:D019636 | Neurodegenerative Diseases | Nimodipine | 4.89 | 16635102 | |
MESH:D020078 | Neurogenic Inflammation | Arsenic | 3.57 | 17056641 | |
MESH:D009503 | Neutropenia | Mustard Gas | 3.18 | 16761898 7688884 | |
MESH:D053206 | Nocturnal Enuresis | Risperidone | 5.45 | 17822346 | |
MESH:D009759 | Nystagmus, Pathologic | Astemizole | 5.58 | 6135121 | |
MESH:D009765 | Obesity | olanzapine | 3.44 | 18515891 | |
MESH:D009771 | Obsessive-Compulsive Disorder | Fluoxetine | 4.65 | 20418887 | |
MESH:D009784 | Occupational Diseases | 4,4'-diaminodiphenylmethane | 2.66 | 6482804 4026338 | |
MESH:D053578 | Opsoclonus-Myoclonus Syndrome | Trazodone | 5.59 | 1318289 | |
MESH:D009902 | Optic Neuritis | 4,4'-diaminodiphenylmethane | 4.14 | 3988306 | |
MESH:D010024 | Osteoporosis | Calcium | 3.19 | 17882678 | |
MESH:D012516 | Osteosarcoma | Doxorubicin | 3.39 | 15930896 | |
MESH:D010051 | Ovarian Neoplasms | Arsenic | 3.79 | 17306315 | |
MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 3.79 | 12452020 19769630 16624393 | |
MESH:D010146 | Pain | Fluoxetine | 7.77 | 12798668 | |
MESH:D010146 | Pain | Imipramine | 7.77 | 12798668 | |
MESH:D010146 | Pain | Trazodone | 7.77 | 12790215 12798668 | |
MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 2.15 | 15580305 | |
MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.88 | 11578682 | |
MESH:D010212 | Papilloma | 4,4'-diaminodiphenylmethane | 6.54 | 7296757 | |
MESH:D010212 | Papilloma | Hydrogen Peroxide | 6.54 | 12065085 | |
MESH:D010235 | Paraganglioma | arsenic trioxide | 3.36 | 19927285 | |
MESH:D010302 | Parkinson Disease, Secondary | Trazodone | 4.90 | 3378227 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 3.37 | 12520081 | |
MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 3.36 | 16093927 | |
MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 4.13 | 15371236 6392382 16905509 | |
MESH:D010787 | Photosensitivity Disorders | 4,4'-diaminodiphenylmethane | 3.59 | 6228378 | |
MESH:D003557 | Phyllodes Tumor | Doxorubicin | 4.28 | 17983394 | |
MESH:D020774 | Pick Disease of the Brain | Fluoxetine | 5.15 | 8041377 | |
MESH:D010997 | Pleural Neoplasms | Doxorubicin | 4.28 | 17638057 | |
MESH:D011020 | Pneumonia, Pneumocystis | Pentamidine | 5.83 | 15340016 | |
MESH:D011041 | Poisoning | Diphenhydramine | 6.95 | 12460839 | |
MESH:D011041 | Poisoning | Mustard Gas | 6.95 | 15727166 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 2.73 | 18163543 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 2.34 | 11222880 11896295 11118676 11399792 | |
MESH:D011471 | Prostatic Neoplasms | Arsenic | 1.93 | 16140617 | |
MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 1.93 | 19131511 | |
MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 1.93 | 16729912 15749863 16888761 16868541 15897917 18437689 | |
MESH:D011471 | Prostatic Neoplasms | Ketoconazole | 1.93 | 17404083 | |
MESH:D011471 | Prostatic Neoplasms | methylselenic acid | 1.93 | 16205645 | |
MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 1.93 | 15067354 | |
MESH:D011471 | Prostatic Neoplasms | Vitamin E | 1.93 | 15084515 | |
MESH:D011507 | Proteinuria | Arsenic | 3.21 | 21343184 | |
MESH:D011537 | Pruritus | Ethinyl Estradiol | 11.41 | 15861022 16919318 | |
MESH:D011537 | Pruritus | fexofenadine | 11.41 | 17133778 | |
MESH:D011537 | Pruritus | Mustard Gas | 11.41 | 18058305 | |
MESH:D011595 | Psychomotor Agitation | Haloperidol | 9.02 | 11575062 | |
MESH:D011595 | Psychomotor Agitation | olanzapine | 9.02 | 18685284 | |
MESH:D011618 | Psychotic Disorders | Haloperidol | 7.32 | 11575062 | |
MESH:D011618 | Psychotic Disorders | Thioridazine | 7.32 | 16882315 | |
MESH:D011657 | Pulmonary Eosinophilia | Trazodone | 5.25 | 8520792 | |
MESH:D011658 | Pulmonary Fibrosis | Amiodarone | 4.41 | 11597910 12490602 12832656 | |
MESH:D011658 | Pulmonary Fibrosis | Mustard Gas | 4.41 | 17620002 17894541 10334151 17266442 17720292 | |
MESH:D012021 | Reflex, Abnormal | Pentobarbital | 5.16 | 10930210 | |
MESH:D051437 | Renal Insufficiency | Doxorubicin | 3.38 | 17922066 | |
MESH:D012131 | Respiratory Insufficiency | Trazodone | 4.96 | 8520792 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.01 | 18990726 | |
MESH:D012162 | Retinal Degeneration | 4,4'-diaminodiphenylmethane | 2.69 | 3692021 | |
MESH:D012221 | Rhinitis, Allergic, Perennial | Astemizole | 14.26 | 10822083 | |
MESH:D012221 | Rhinitis, Allergic, Perennial | mizolastine | 14.26 | 18020585 | |
MESH:D012221 | Rhinitis, Allergic, Perennial | Terfenadine | 14.26 | 8201490 | |
MESH:D006255 | Rhinitis, Allergic, Seasonal | mizolastine | 6.03 | 18020585 | |
MESH:D012509 | Sarcoma | Doxorubicin | 3.23 | 16767912 17203757 15625365 18313854 17710206 15675481 | |
MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 7.55 | 16646077 | |
MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 7.55 | 16326096 14601052 | |
MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.93 | 17846226 | |
MESH:D012559 | Schizophrenia | Haloperidol | 6.28 | 19369910 20107430 18513383 1830565 | |
MESH:D012559 | Schizophrenia | olanzapine | 6.28 | 20107430 17726453 20521326 | |
MESH:D012559 | Schizophrenia | Risperidone | 6.28 | 18278980 19154706 20107430 | |
MESH:D012559 | Schizophrenia | Trazodone | 6.28 | 7868106 | |
MESH:D012640 | Seizures | gabapentin | 9.21 | 10454489 | |
MESH:D012640 | Seizures | lamotrigine | 9.21 | 9844417 16499746 | |
MESH:D012640 | Seizures | Pentobarbital | 9.21 | 10087439 9754883 | |
MESH:D012640 | Seizures | topiramate | 9.21 | 16499746 | |
MESH:D020230 | Serotonin Syndrome | Fluoxetine | 10.38 | 8704074 | |
MESH:D020230 | Serotonin Syndrome | Trazodone | 10.38 | 7854515 8704074 9050436 | |
OMIM:608579 | SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO | lamotrigine | 5.75 | 20485159 19668019 | |
MESH:D012772 | Shock, Septic | Diphenhydramine | 5.61 | 18063050 | |
OMIM:609620 | SHORT QT SYNDROME 1 | marker/mechanism | 18724381 | ||
OMIM:609620 | SHORT QT SYNDROME 1 | Amiodarone | 4.22 | 18724381 | |
MESH:D012852 | Sinusitis | Phenylephrine | 3.84 | 7327846 | |
MESH:D012871 | Skin Diseases | Arsenic | 6.06 | 17050553 19834688 16759981 17453740 16702368 17548696 17938729 16353154 18709164 15952646 6392382 | |
MESH:D012871 | Skin Diseases | Mustard Gas | 6.06 | 16961503 12880345 15451306 | |
MESH:D012871 | Skin Diseases | Vitamin E | 6.06 | 18709164 | |
MESH:D012878 | Skin Neoplasms | Arsenic | 9.48 | 17976673 15504454 19538983 17050553 16251483 17029826 | |
MESH:D012878 | Skin Neoplasms | Doxorubicin | 9.48 | 15692506 | |
MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 9.48 | 12065085 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 9.48 | 16192470 | |
MESH:D012892 | Sleep Deprivation | Imipramine | 10.99 | 19798453 | |
MESH:D012892 | Sleep Deprivation | Trazodone | 10.99 | 19798453 | |
MESH:D012893 | Sleep Disorders | Risperidone | 8.76 | 18278980 | |
MESH:D012893 | Sleep Disorders | Trazodone | 8.76 | 19395429 | |
MESH:D007319 | Sleep Initiation and Maintenance Disorders | Trazodone | 4.57 | 17225163 15062207 15341891 | |
MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 3.72 | 17203757 15625365 16767912 | |
MESH:D013088 | Spermatocele | Ethinyl Estradiol | 8.65 | 16709447 | |
MESH:D013088 | Spermatocele | Tamoxifen | 8.65 | 16709447 | |
MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 3.18 | 19457130 | |
MESH:D013262 | Stevens-Johnson Syndrome | lamotrigine | 5.26 | 20235791 | |
MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 1.88 | 17007042 | |
MESH:D013276 | Stomach Ulcer | Amiodarone | 2.58 | 18087811 | |
MESH:D020521 | Stroke | Trazodone | 6.80 | 810300 | |
MESH:D020521 | Stroke | Vitamin E | 6.80 | 16517955 | |
MESH:D013375 | Substance Withdrawal Syndrome | Pentobarbital | 8.13 | 11529278 9754883 | |
MESH:D013375 | Substance Withdrawal Syndrome | Trazodone | 8.13 | 12749364 393279 | |
MESH:D013610 | Tachycardia | Amiodarone | 3.47 | 11238279 | |
MESH:D017180 | Tachycardia, Ventricular | Amiodarone | 29.64 | 19225199 | |
MESH:D017180 | Tachycardia, Ventricular | Haloperidol | 29.64 | 20210726 | |
MESH:D017180 | Tachycardia, Ventricular | olanzapine | 29.64 | 20210726 | |
MESH:D017180 | Tachycardia, Ventricular | Risperidone | 29.64 | 20210726 | |
MESH:D017180 | Tachycardia, Ventricular | Thioridazine | 29.64 | 20210726 | |
MESH:D017180 | Tachycardia, Ventricular | Trazodone | 29.64 | 2424891 | |
MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.81 | 11994571 | |
MESH:D013927 | Thrombosis | Ethinyl Estradiol | 2.41 | 15669648 | |
MESH:D013959 | Thyroid Diseases | Amiodarone | 9.14 | 19731979 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 9.14 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | 4,4'-diaminodiphenylmethane | 8.02 | 1399818 6582329 7505956 6587162 3712494 | |
MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 8.02 | 19014326 | |
MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 8.02 | 17909728 16010429 | |
MESH:D013971 | Thyrotoxicosis | Amiodarone | 4.01 | 19584973 18020914 | |
MESH:D016171 | Torsades de Pointes | marker/mechanism | 15213294 | ||
MESH:D016171 | Torsades de Pointes | Amiodarone | 41.74 | 11989578 17467628 | |
MESH:D016171 | Torsades de Pointes | arsenic trioxide | 41.74 | 15213294 | |
MESH:D016171 | Torsades de Pointes | Astemizole | 41.74 | 8256756 9583453 | |
MESH:D016171 | Torsades de Pointes | Flecainide | 41.74 | 17467628 | |
MESH:D016171 | Torsades de Pointes | Metoprolol | 41.74 | 19353679 | |
MESH:D016171 | Torsades de Pointes | Propafenone | 41.74 | 17467628 | |
MESH:D016171 | Torsades de Pointes | Sotalol | 41.74 | 11989578 17467628 | |
MESH:D016171 | Torsades de Pointes | Terfenadine | 41.74 | 8256756 | |
MESH:D005879 | Tourette Syndrome | Risperidone | 5.10 | 19154706 | |
MESH:D014202 | Tremor | Pimozide | 5.69 | 17594079 19467297 | |
MESH:D014352 | Trypanosomiasis | Pentamidine | 5.63 | 15340016 | |
MESH:D001749 | Urinary Bladder Neoplasms | 4,4'-diaminodiphenylmethane | 11.10 | 8074119 | |
MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 11.10 | 11144890 15987713 17976673 17306315 19322015 19429237 18640142 | |
MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 11.10 | 12973940 20435036 12845720 11780464 | |
MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 11.10 | 17653716 | |
MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 11.10 | 16712894 17572228 8653321 | |
MESH:D014581 | Urticaria | Astemizole | 14.81 | 2885854 3080510 2859714 2565098 2568189 1976298 3134034 2883202 1683191 2568013 2147912 3097109 | |
MESH:D014581 | Urticaria | Loratadine | 14.81 | 2568013 | |
MESH:D014581 | Urticaria | mizolastine | 14.81 | 18020585 | |
MESH:D014581 | Urticaria | Terfenadine | 14.81 | 2569995 2565098 2859714 2568013 2885854 | |
MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 2.48 | 14692618 | |
MESH:D014652 | Vascular Diseases | Arsenic | 3.87 | 17056641 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.71 | 12125929 | |
MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.75 | 14671159 15869587 | |
MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 3.38 | 17334414 17638931 17678736 16364871 | |
MESH:D018879 | Ventricular Premature Complexes | Trazodone | 5.94 | 2424891 | |
MESH:D014717 | Vertigo | Astemizole | 5.58 | 3105558 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.37 | 15886252 | |
MESH:D015430 | Weight Gain | olanzapine | 8.14 | 20107430 17933447 19434072 | |
MESH:D015430 | Weight Gain | Risperidone | 8.14 | 20564506 16379507 |
No data |
Releated gene ID | Related gene Name |
---|---|
PA134936082 | ALG10B |
PA212 | KCNH2 |
Releated disease ID | Related disease Name |
---|---|
PA443421 | Arrhythmias, Cardiac |
PA443459 | Atrial Fibrillation |
PA159018367 | Brugada syndrome |
PA443633 | Cardiomyopathy, Hypertrophic |
PA443796 | Coronary Artery Disease |
PA443797 | Coronary Disease |
PA446379 | Death, Sudden, Cardiac |
PA444368 | Heart Diseases |
PA445019 | Myocardial Infarction |
PA445769 | Sudden Infant Death |
PA445848 | Thromboembolism |
PA446028 | Ventricular Fibrillation |
PA443224 | Abnormalities, Drug-Induced |
PA447300 | Acquired Long QT Syndrome (aLQTS) |
PA444807 | Long QT Syndrome |
PA446294 | Torsades de Pointes |
PA447228 | congenital long QT syndrome |
PA446450 | Tachycardia, Ventricular |
Releated drug ID | Related drug Name |
---|---|
PA164712547 | Beta blocking agents, selective |
PA451906 | warfarin |
PA448498 | astemizole |
PA449011 | cisapride |
PA449812 | grepafloxacin |
PA164784002 | sertindole |
PA451619 | terfenadine |
PA449493 | erythromycin |
PA450555 | moxifloxacin |
PA10202 | telithromycin |
PA130150436 | perhexiline |
PA449422 | droperidol |
PA450215 | levomethadyl acetate |
PA450492 | mibefradil |
PA449373 | disopyramide |
PA449958 | ibutilide |
PA450688 | olanzapine |
PA450965 | pimozide |
PA451201 | quetiapine |
PA451257 | risperidone |
PA451472 | sparfloxacin |
PA451666 | thioridazine |
PA451974 | ziprasidone |
PA451108 | procainamide |
PA448486 | arsenic trioxide |
PA448960 | chlorpheniramine |
PA449001 | cimetidine |
PA449841 | haloperidol |
PA450266 | loratadine |
PA450272 | lovastatin |
PA449409 | doxepin |
PA451107 | probucol |
PA449389 | dofetilide |
PA449673 | fluoxetine |
PA449690 | fluvoxamine |
PA449943 | hydroxyzine |
PA451744 | trazodone |
PA452233 | antipsychotics |
PA164754755 | bepridil |
PA448948 | chloroquine |
PA448964 | chlorpromazine |
PA134711056 | domperidone |
PA449839 | halofantrine |
PA450386 | mesoridazine |
PA448383 | amiodarone |
PA451457 | sotalol |
PA450850 | pentamidine |
PA450401 | methadone |
PA451209 | quinidine |
PA450488 | mexiletine |
PA452249 | antiarrhythmics, class i and iii |
PA449028 | clarithromycin |
PA165291889 | silodosin |
Drugbank ID | Action | Drug Name | Description |
---|---|---|---|
DB00204 | antagonist | Dofetilide | Antiarrhythmic Agents;Potassium Channel Blockers;Anti-Arrhythmia Agents |
DB00276 | antagonist | Amsacrine | Antineoplastic Agents;Intercalating Agents |
DB00308 | inhibitor | Ibutilide | Anti-Arrhythmia Agents |
DB00342 | antagonist | Terfenadine | Antiarrhythmic Agents;Anti-Allergic Agents;Antihistamines;Histamine H1 Antagonists, Non-Sedating |
DB00457 | antagonist | Minizide | Antihypertensive Agents;Adrenergic alpha-Antagonists;Alpha-adrenergic Blocking Agents |
DB00489 | inhibitor | Sotalol | Adrenergic beta-Antagonists;Sympatholytics;Anti-Arrhythmia Agents |
DB00590 | antagonist | Doxazosin | Antineoplastic Agents;Antihypertensive Agents;Vasodilator Agents;Adrenergic alpha-Antagonists;Alpha-adrenergic Blocking Agents;Antihyperplasia Agents |
DB00604 | antagonist | Cisapride | Anti-Ulcer Agents;Gastrointestinal Agents;Serotonin Agonists;Prokinetic Agents |
DB00637 | antagonist | Astemizole | Anti-Allergic Agents;Antihistamines;Histamine H1 Antagonists, Non-Sedating |
DB00661 | blocker | Tarka | Vasodilator Agents;Antiarrhythmic Agents;Calcium Channel Blockers;Anti-Arrhythmia Agents |
DB00679 | antagonist | Thioridazine | Antipsychotics;Dopamine Antagonists;Phenothiazines;Antipsychotic Agents |
DB00908 | antagonist | Quinidine | Enzyme Inhibitors;Antiarrhythmic Agents;Antimalarials;Muscarinic Antagonists;Adrenergic alpha-Antagonists;Anti-Arrhythmia Agents |
DB01100 | antagonist | Pimozide | Dopamine Antagonists;Antipsychotic Agents;Anti-Dyskinesia Agents |
DB01110 | antagonist | Miconazole | Antifungal Agents |
DB01118 | antagonist | Amiodarone | Vasodilator Agents;Enzyme Inhibitors;Anti-Arrhythmia Agents |
DB01136 | inhibitor | Carvedilol | Antihypertensive Agents;Adrenergic Agents;Adrenergic beta-Antagonists;Vasodilator Agents;Adrenergic alpha-Antagonists |
DB01162 | inhibitor | Terazosin | Antineoplastic Agents;Adrenergic alpha-Antagonists |
DB01182 | antagonist | Propafenone | Anti-Arrhythmia Agents |
DB01218 | antagonist | Halofantrine | Antiprotozoals;Antimalarials |
DB06144 | antagonist | Sertindole | Neuroleptics;Antipsychotic Agents |
No data |
No data |
No data |